Biohacking Market: Information by Type (Outside Biohacking), Product (Smart Drugs), Application (Genetic Engineering), End-User (Forensic Laboratories), and Region — Forecast till 2029

Oct 14, 2020   Market Overview Biohacking refers to the use of medications that boost functionality or the use of external or internal implants in individuals to enhance cognitive performance, memory, and imagination. The most efficient approach includes the ingestion of nootropic medications to improve intelligence and attention. It is even referred to as biology for do-it-yourself (DIY). In storage rooms, garages, and other such places, biohackers have set up shop. Biogarage, Bioartlab, Genspace, BioCurious...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis:  Biohacking Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Top wining strategies

3.7       Top investment pockets

3.8       Impact of COVID-19 on  Biohacking Market

4          Type Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Outside Biohacking

4.2.1   Market Size & Forecast (Value)

4.3       Inside Biohacking

4.3.1   Market Size & Forecast (Value)

5          Product Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Smart Drugs

5.2.1   Market Size & Forecast (Value)

5.3       Sensors

5.3.1   Market Size & Forecast (Value)

5.4       Strains

5.4.1   Market Size & Forecast (Value)

5.5       Other Products

5.5.1   Market Size & Forecast (Value)

6          Application Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Genetic Engineering

6.2.1   Market Size & Forecast (Value)

6.3       Synthetic Biology

6.3.1   Market Size & Forecast (Value)

6.4       Diagnosis & Treatment

6.4.1   Market Size & Forecast (Value)

6.5       Drug Testing

6.5.1   Market Size & Forecast (Value)

6.6       Forensic Science

6.6.1   Market Size & Forecast (Value)

6.7       Other Applications

6.7.1   Market Size & Forecast (Value)

7          End-User Overview

7.1       Introduction

7.1.1   Market Size & Forecast (Value)

7.2       Pharmaceutical & Biotechnology Companies

7.2.1   Market Size & Forecast (Value)

7.3       Forensic Laboratories

7.3.1   Market Size & Forecast (Value)

7.3       Others

7.3.1   Market Size & Forecast (Value)

8          Regional Overview

8.1      Introduction

8.1.1   Market Size & Forecast (Value)

8.2      North America

8.2.1   North America

8.2.1.1      The U.S.

8.2.1.1.1         By Type

8.2.1.1.2         By Product

8.2.1.2      Canada

8.2.1.2.1         By Type

8.2.1.2.2         By Product

8.2.1.3      Mexico

8.2.1.3.1         By Type

8.2.1.3.2         By Product

8.2.2   Central and South America and the Caribbean

8.2.2.1      By Type

8.2.2.2      By Product

8.2.2.2.1   Brazil

8.2.2.2.1.1      By Type

8.2.2.2.1.2      By Product

8.2.2.2.2   Argentina

8.2.2.2.2.1      By Type

8.2.2.2.2.2      By Product

8.2.2.2.3   The Rest of Central and South America and the Caribbean

8.2.2.2.3.1      By Type

8.2.2.2.3.2      By Product

8.3      Europe

8.3.1   Market Size & Forecast (Value)

8.3.2   Western Europe

8.3.2.1      The U.K.

8.3.2.1.1         By Type

8.3.2.1.2         By Product

8.3.2.2      Germany

8.3.2.2.1         By Type

8.3.2.2.2         By Product

8.3.2.3      France

8.3.2.3.1         By Type

8.3.2.3.2         By Product

8.3.2.4      Spain

8.3.2.4.1         By Type

8.3.2.4.2         By Product

8.3.2.5      Italy

8.3.2.5.1         By Type

8.3.2.5.2         By Product

8.3.2.8      The Rest of Western Europe

8.3.2.8.1         By Type

8.3.2.8.2         By Product

8.3.3   Eastern Europe

8.3.3.1  By Type

8.3.3.2  By Product

8.3.4   The Rest of Europe

8.3.4.1  By Type

8.3.4.2  By Product

8.4      Asia Pacific

8.4.1   Market Size & Forecast (Value)

8.4.2   Japan

8.4.2.1            By Type

8.4.2.2            By Product

8.4.3   China

8.4.3.1            By Type

8.4.3.2            By Product

8.4.4   Australia

8.4.4.1            By Type

8.4.4.2            By Product

8.4.5   India

8.4.5.1            By Type

8.4.5.2            By Product

8.4.8   South Korea

8.4.8.1            By Type

8.4.8.2            By Product

8.4.8   The Rest of Asia-Pacific

8.4.8.1            By Type

8.4.8.2            By Product

8.5      The Middle East& Africa

8.5.1   The Middle East

8.5.1.1            Market Size & Forecast (Value)

8.5.1.2            Saudi Arabia

8.5.1.2.1         By Type

8.5.1.2.2         By Product

8.5.1.3            The UAE

8.5.1.3.1         By Type

8.5.1.3.2         By Product

8.5.1.4            Qatar

8.5.1.4.1         By Type

8.5.1.4.2         By Product

8.5.2   The Africa

8.5.2.1            Market Size & Forecast (Value)

9          Company Profile

9.1      Apple Inc.

9.1.1   Company Overview

9.1.2   Financial Performance

9.1.3   Recent Developments

9.1.4   Type Portfolio

9.2      Fitbit, Inc.

9.2.1   Company Overview

9.2.2   Financial Performance

9.2.3   Recent Developments

9.2.4   Type Portfolio

9.3      Synbiota, Inc.

9.3.1   Company Overview

9.3.2   Financial Performance

9.3.3   Recent Developments

9.3.4   Type Portfolio

9.4      The ODIN

9.4.1   Company Overview

9.4.2   Financial Performance

9.4.3   Recent Developments

9.4.4   Type Portfolio

9.5      HVMN Inc.

9.5.1   Company Overview

9.5.2   Financial Performance

9.5.3   Recent Developments

9.5.4   Type Portfolio

9.6      Thync  Inc.

9.6.1   Company Overview

9.6.2   Financial Performance

9.6.3   Recent Developments

9.6.4   Type Portfolio

9.7      Moodmetric

9.7.1   Company Overview

9.7.2   Financial Performance

9.7.3   Recent Developments

9.7.4   Type Portfolio

9.8      InteraXon Inc.

9.8.1   Company Overview

9.8.2   Financial Performance

9.8.3   Recent Developments

9.8.4   Type Portfolio

9.9      Behavioral Tech.

9.9.1   Company Overview

9.9.2   Financial Performance

9.9.3   Recent Developments

9.9.4   Type Portfolio

10        Conclusion & Recommendations

11        Acronyms & Abbreviations

Copyright . All rights Reserved By Straits Research